Journey Strategic Wealth LLC Becton Dickinson & CO Transaction History

Journey Strategic Wealth LLC

$2.71 Billion
Q3 2024

A detailed history of Journey Strategic Wealth LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Journey Strategic Wealth LLC holds 1,368 shares of BDX stock, worth $304,571. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,368

Previous 1,246 9.79%

Holding current value

$304,571

Previous $291,000 13.06%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$221.47 - $242.41 $27,019 - $29,574	122 Added 9.79%	1,368 $329,000
Q2 2024 Aug 14, 2024	BUY	$225.07 - $246.17 $25,432 - $27,817	113 Added 9.97%	1,246 $291,000
Q1 2024 May 13, 2024	SELL	$233.45 - $247.73 $58,829 - $62,427	-252 Reduced 18.19%	1,133 $280,000
Q4 2023 Feb 09, 2024	SELL	$232.24 - $267.23 $928 - $1,068	-4 Reduced 0.29%	1,385 $337,000
Q3 2023 Nov 08, 2023	SELL	$254.9 - $283.59 $23,960 - $26,657	-94 Reduced 6.34%	1,389 $359,000
Q2 2023 Aug 14, 2023	SELL	$238.39 - $265.32 $69,848 - $77,738	-293 Reduced 16.5%	1,483 $391,000
Q1 2023 May 11, 2023	BUY	$229.71 - $259.35 $16,998 - $19,191	74 Added 4.35%	1,776 $439,000
Q4 2022 Feb 14, 2023	SELL	$218.29 - $256.91 $6,985 - $8,221	-32 Reduced 1.85%	1,702 $432,000
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $16,329 - $84,553	320 Added 22.63%	1,734 $386,000
Q2 2022 Aug 15, 2022	SELL	$234.74 - $275.42 $67,135 - $78,770	-286 Reduced 16.82%	1,414 $349,000
Q1 2022 May 16, 2022	BUY	$243.64 - $270.48 $3,898 - $4,327	16 Added 0.95%	1,700 $453,000
Q4 2021 Feb 14, 2022	BUY	$230.08 - $250.94 $387,454 - $422,582	1,684 New	1,684 $423,000

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

250M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.5B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Journey Strategic Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Journey Strategic Wealth LLC with notifications on news.

Account

Journey Strategic Wealth LLC Becton Dickinson & CO Transaction History